Jade Biosciences (JBIO) Current Assets (2020 - 2026)
Jade Biosciences (JBIO) reported Current Assets of $471.25 million for Q2 2026, up 111.3% from $222.98 million a year earlier and up 48.0% from the prior quarter.
Jade Biosciences (JBIO) Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Jade Biosciences posted Current Assets of $348.82 million, up 400.8% from FY2024.
- Current Assets has a five-year compound annual growth rate of 136.9% (FY2020 to FY2025).
- By year, Current Assets came in at $69.65 million in FY2024 (-43.9%), $124.23 million in FY2023 (-5.5%), $131.5 million in FY2022 (-24.6%) and $174.33 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Current Assets in data going back to Q4 2020.
- Year over year, Current Assets has now increased in each of the last five quarters, with growth averaging 118.0% over the last eight quarters.
- The high point for year-over-year Current Assets in five years was Q4 2025 (growth of 400.8%); the low point was Q4 2024 (a decline of 43.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $318.52 million (Q1 2026), $348.82 million (Q4 2025) and $201.36 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Jade Biosciences | 912.03 Mn | 912.03 Mn | - | 471.25 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 471.25 Mn |
| Mar 31, 2026 | 318.52 Mn |
| Dec 31, 2025 | 348.82 Mn |
| Sep 30, 2025 | 201.36 Mn |
| Jun 30, 2025 | 222.98 Mn |
| Mar 31, 2025 | 77.37 Mn |
| Dec 31, 2024 | 69.65 Mn |
| Sep 30, 2024 | 90.61 Mn |
| Jun 30, 2024 | 110.76 Mn |
| Mar 31, 2024 | 103.24 Mn |
| Dec 31, 2023 | 124.23 Mn |
| Sep 30, 2023 | 137.60 Mn |
| Jun 30, 2023 | 152.47 Mn |
| Mar 31, 2023 | 120.57 Mn |
| Dec 31, 2022 | 131.50 Mn |
| Sep 30, 2022 | 145.16 Mn |
| Jun 30, 2022 | 153.45 Mn |
| Mar 31, 2022 | 165.89 Mn |
| Dec 31, 2021 | 174.33 Mn |
| Sep 30, 2021 | 183.10 Mn |
Jade Biosciences Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=JBIO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "JBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=JBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();